Thank you to all who joined us live Primary Care Pulse on February 2, 2021. If you were not able to join us live, the sessions have been recorded and are available below.
Upcoming Virtual Programs
Agenda
CME/CE Accredited Session
Non-CME/CE Session
Sponsored by Industry
Click For Session Details
Session Times Listed in ET
12–1pm ET CME/CE Accredited Session
Understanding and Improving Vaccine Hesitancy in African American Patients
Gregory L. Hall, MD
This session will provide an overview of the health disparities related to the acceptance of vaccines among racial and ethnic groups in the US. We will discuss the historical basis for some of the apprehensions that exist in the African American community. We will look at conspiracy theories that are circulated regarding vaccines and discuss ways to reassure patients about the safety and any real risks. Finally, we will discuss best practices related to COVID-19 vaccine discussions with patients who are hesitant to accept.
Gregory L. Hall, MD
Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, Director, Center for African American Health, Research, Education & Policy, Cleveland, OH
1:10–1:55pm ET Non-CME Industry Theater
Early Recognition of Interstitial Lung Disease
Justin Oldham, MD, MS
During this virtual Industry Theater presentation, an expert pulmonologist who specializes in the field of interstitial lung diseases (ILDs) will discuss the complexity of ILD recognition, with a focus on diagnostic criteria and the importance of collaborating with specialists for a timely diagnosis of ILDs
This content is developed exclusively by or on behalf of the industry sponsor; it is not reviewed or associated with Pri-Med and Pri-Med does not endorse or sanction any third-party content.
Justin Oldham, MD, MS
Director, Interstitial Lung Disease Program, The University of California at Davis
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC